19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT, with a corresponding application number 21810 and regulatory information .
proudly manufactured in the
Novo Nordisk's NOVOLOG MIX 50/50 INJECTABLE;SUBCUTANEOUS, medication with 50 UNITS/ML;50 UNITS/ML of INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT.